The Cooper Companies, Inc. acquires Marlow Surgical Technologies, Inc.; continues consolidation of gynecology market.IRVINE, Calif.--(BW HealthWire)--April 7, 1997--The Cooper Companies, Inc., (NYSE/PSE:COO) announced today that it has completed the acquisition of Marlow Surgical Technologies, Inc., a highly regarded, privately held gynecology products company. Marlow develops and markets minimally invasive surgical products and disposable products for reproductive medicine. Cooper will integrateSurgical in fiscal 1996 were $1 7.2 million with re during 1997 and is expected to contribute pry, well-differentiated products, especially tterine manipulation and fertility management, aned system for controlling and positionin g the uts. These p roducts include the VerreScope systemves operative control and reduces patient trauicantly augment its reproductive medicine lineattractive emerging medical device market. Acvisits and perform over two million surgical pal centers and now, increasingly, to the physicisitions, decision s to invest in research and d debt restructuring Debt Restructuring A method used by companies with outstanding debt obligations to alter the terms of the debt agreements in order to achieve some advantage. Notes: , decisions to divest busintes. The Company expects HGA HGA High-Gain Antenna HGA Handweavers Guild of America HGA Hammel Green and Abrahamson HGA Hercules Graphics Adapter HGA Homogentisic Acid HGA Honor Guard Academy HGA Holy Guardian Angels (Reading, PA catholic church) revenue and operating income Operating Income The profit realized from a business' own operations. Notes: This would not include income from things such as investments in other firms. Also referred to as operating profit or recurring profit. in 1997 to achieve double-digit growth through new outpatient clinics, geriatric programs and lower cost residential treatment services, assuming that patient revenue and operating expenses Operating expenses The amount paid for asset maintenance or the cost of doing business, excluding depreciation. Earnings are distributed after operating expenses are deducted. can continue successfully to adjust to changes in third party reimbursement rates for psychiatric care. The Company expects consolidated revenue and operating income to grow by more than 15% and 30%, respectively, in 1997 and anticipates earnings per share in the range of $1.45 to $1.55 excluding a deferred tax benefit of about 15 cents per share Cents per share The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned. . In 1998, Cooper estimates that earnings per share before the deferred tax benefit will be approximately $2.00. The Cooper Companies, Inc. and its subsidiaries develop, manufacture and market specialty healthcare products and services. CooperSurgical, Inc., headquars, equipment and accessories for the gynecologoad range of contact lenses for the vision care NOTE: An interactive telephone syste m that pr available at www.coopercos.com on the Internet. VerreScope(tm), The RUMI System(tm), Nu-Tip(r), KOH KOH The chemical formula for potassium hydroxide, which is used to perform the KOH test. The tests is also called a potassium hydroxide preparation. Mentioned in: KOH Test KOH potassium hydroxide. -CB/np* CONTACT: The Cooper Companies, Ith Hyperlinks to your home page. URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. : http://www.businesswire.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion